ERVCELLS
LIVE

Serial Number

97910470

Owner

ERVIMMUNE

Attorney

Pina Campagna

Filing Date

Apr 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ERVCELLS Trademark

Serial Number: 97910470

ERVCELLS is a trademark filed by ERVIMMUNE on April 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ERVIMMUNE (3 trademarks)

CENTRE L�ON B�RARD 28 RUE LAENNEC
LYON CEDEX 08 69373 , FR

Entity Type: 99

Ervaccine Technologies (3 trademarks)

Centre Léon Bérard 28 Rue Laennec
Lyon Cedex 08 69373 , FR

Entity Type: 99

Trademark Details

Filing Date

April 27, 2023

Registration Date

Not Registered

Published for Opposition

January 7, 2025

Goods & Services

Pharmaceutical preparations for the treatment of cancer; therapeutic vaccines; Medical preparations, namely, T-cell therapy preparations for the treatment of cancer; stem cells for medical use; biological preparations for the prevention and treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of cancer; chemical preparations for medical purposes, namely, for the prevention or treatment of cancer; diagnostic preparations for medical purposes; medicinal preparations for the treatment of infectious diseases and for use in immunotherapy and oncology

Medical and surgical services in the field of immunotherapy and oncology; medical diagnosis in the field of oncology, namely, medical diagnosis of cancer; medical testing for diagnostic or treatment purposes; provision of medical information in the field of immunotherapy and oncology; medical analysis for the diagnosis and treatment of persons; genetic testing services for medical purposes

Medical research laboratory services; biotechnological and pharmaceutical drug research and development services; pharmaceutical and biotechnological research and development; provision of medical and scientific research information in the field of pharmaceuticals; provision of medical and scientific research information in the field of therapeutic vaccines; provision of medical and scientific research information in the field of oncology, immunotherapy, stem cell therapy, and T-cell therapy; Providing medical and scientific research information in the field of clinical trials; screening and selection of molecules for scientific and pharmacological research purposes, not for medical purposes; research and development in the field of immunotherapy

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2024 CNSA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 6, 2024 ASGN
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 9, 2024 CRFA
ASSIGNED TO LIE
Aug 9, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 25, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 25, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 25, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 25, 2023 NWOS
NEW APPLICATION ENTERED
May 1, 2023 NWAP